» Articles » PMID: 30758470

ALVEOLAR BONE PATTERN AND SALIVARY LEPTIN LEVELS AMONG PREMENOPAUSAL OBESE WOMEN

Overview
Date 2019 Feb 14
PMID 30758470
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Systemic bone loss may lead to more severe periodontal destruction, decreasing local bone mineral density.

Aim: A cross-sectional designed was performed to study associations among alveolar bone pattern, salivary leptin concentrations, and clinical periodontal status in premenopausal obese and eutrophic women.

Methods: Thirty morbid obese (G1) and 30 normal-weight (G2) women were included. Anthropometric and periodontal measurements (probing depth - PD, clinical attachment levels - CAL, presence of calculus, bleeding on probing -BOP, and plaque accumulation) were assessed. OHIP-14 was used for assessment of oral health impact on quality of life. Panoramic radiography was used to obtain the panoramic mandibular index (PMI), mandibular cortical index (MCI), and mental index (MI). Intraoral periapical (PA) radiography was taken to measure the total trabecular bone volume. Leptin was measured in saliva of fasted overnight women.

Results: Groups 1 and 2 differed in all anthropometric aspects, but height. Pocket depth, calculus, BOP, and plaque index were worse in G1. No differences between groups were found considering OHIP. Normal-weight subjects showed higher proportion of dense bone trabeculae than obese subjects for pre-molars, but not for molars. Mental and panoramic mandibular indexes did not differ and were in normal level. Leptin concentration was dependent only on BMI.

Conclusion: Obesity affected the periodontal conditions, the alveolar bone pattern, and the salivary leptin concentration.

Citing Articles

ASSESSMENT OF ALVEOLAR BONE PATTERN IN OBESE AND NON-OBESE WOMEN, BEFORE AND AFTER BARIATRIC SURGERY: A PROSPECTIVE COHORT STUDY.

Vargas J, Soares Bonato R, Orenha E, Sales-Peres S Arq Bras Cir Dig. 2020; 33(1):e1501.

PMID: 32667531 PMC: 7357551. DOI: 10.1590/0102-672020190001e1501.

References
1.
Cornish J, Callon K, Bava U, Lin C, Naot D, Hill B . Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J Endocrinol. 2002; 175(2):405-15. DOI: 10.1677/joe.0.1750405. View

2.
Farr O, Gavrieli A, Mantzoros C . Leptin applications in 2015: what have we learned about leptin and obesity?. Curr Opin Endocrinol Diabetes Obes. 2015; 22(5):353-9. PMC: 4610373. DOI: 10.1097/MED.0000000000000184. View

3.
Horowitz M, Xi Y, Wilson K, Kacena M . Control of osteoclastogenesis and bone resorption by members of the TNF family of receptors and ligands. Cytokine Growth Factor Rev. 2001; 12(1):9-18. DOI: 10.1016/s1359-6101(00)00030-7. View

4.
Abella V, Scotece M, Conde J, Pino J, Gonzalez-Gay M, Gomez-Reino J . Leptin in the interplay of inflammation, metabolism and immune system disorders. Nat Rev Rheumatol. 2017; 13(2):100-109. DOI: 10.1038/nrrheum.2016.209. View

5.
Salamat M, Salamat A, Janghorbani M . Association between Obesity and Bone Mineral Density by Gender and Menopausal Status. Endocrinol Metab (Seoul). 2016; 31(4):547-558. PMC: 5195832. DOI: 10.3803/EnM.2016.31.4.547. View